Michael Sitzman > DLA Piper LLP (US) > San Francisco, United States > Lawyer Profile
DLA Piper LLP (US) Offices
555 MISSION STREET, SUITE 2400
SAN FRANCISCO, CA 94105-2933
CALIFORNIA
United States
- Firm Profile
- Go to...
Michael Sitzman
Work Department
Intellectual Property; Life Sciences Intellectual Property; Patent Litigation
Position
Partner; US Chair Life Sciences Patent Litigation
Lawyer Rankings
United States > Intellectual property > Patents: litigation (International Trade Commission)
Co-led by seasoned ITC litigator and tech expert Erin Gibson
in San Diego, DLA Piper LLP (US)
has a broad ITC practice with expertise in a variety of issues relating to Section 337 actions. The group is particularly strong in tech and recently successfully defended Lenovo Group Ltd and Motorola Mobility LLC against a wide-reaching claim by Maxell Technologies. San Diego co-head Sean Cunningham frequently handles matters relating to tech, medical devices and power equipment at the ITC. Mark Fowler in Palo Alto is also an expert in medical devices and power equipment-related cases, acting for clients such as Honeywell and Samsung, and Helena Kiepura in Washington DC is a Section 337 expert. Practice co-heads Gina Durham and Michael Sitzman are based in San Francisco and handle a wide range of patent disputes. Daniel Valencia joined the the DC team in August 2023 from Covington & Burlington, and is another well versed trial lawyer at the ITC.
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- International trade > CFIUS
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Insurance > Advice to insurers
- Industry focus > Cannabis
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Antitrust > Cartel
- Intellectual property > Copyright
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Dispute resolution > International arbitration
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Project finance
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Transport > Rail and road: litigation and regulation
- International trade > CFIUS